Senzime Successfully Unveils Next-Generation TetraGraph® Quantitative Train-of-Four Monitor at ANESTHESIOLOGY® 2024; U.S. Shipments Begin Q4 2024
Senzime has unveiled its next-generation TetraGraph® system at ANESTHESIOLOGY® 2024, featuring advanced monitoring capabilities for neuromuscular block during surgery. The system includes TetraGraph® Adaptive Intelligence™, offering automated workflows and real-time data monitoring. Key improvements include a revolutionary user interface with Level-of-Block Gauge™ and a 6th generation EMG algorithm with 4x higher resolution. The company announced that U.S. shipments will begin in Q4 2024, with the system designed to reduce complications from residual neuromuscular block in surgical patients.
Senzime ha presentato il suo sistema di nuova generazione TetraGraph® all'ANESTHESIOLOGY® 2024, dotato di avanzate funzionalità di monitoraggio per il blocco neuromuscolare durante gli interventi chirurgici. Il sistema include TetraGraph® Adaptive Intelligence™, che offre flussi di lavoro automatizzati e monitoraggio dei dati in tempo reale. Tra i miglioramenti chiave ci sono un'interfaccia utente rivoluzionaria con il Level-of-Block Gauge™ e un algoritmo EMG di sesta generazione con risoluzione 4 volte superiore. La compagnia ha annunciato che le spedizioni negli Stati Uniti inizieranno nel quarto trimestre del 2024, con il sistema progettato per ridurre le complicazioni dal blocco neuromuscolare residuo nei pazienti chirurgici.
Senzime ha revelado su sistema de nueva generación TetraGraph® en ANESTHESIOLOGY® 2024, que presenta capacidades avanzadas de monitoreo para el bloqueo neuromuscular durante la cirugía. El sistema incluye TetraGraph® Adaptive Intelligence™, que ofrece flujos de trabajo automatizados y monitoreo de datos en tiempo real. Las mejoras clave incluyen una interfaz de usuario revolucionaria con el Level-of-Block Gauge™ y un algoritmo EMG de sexta generación con 4 veces más resolución. La empresa anunció que los envíos a EE. UU. comenzarán en el cuarto trimestre de 2024, con el sistema diseñado para reducir las complicaciones por bloqueo neuromuscular residual en pacientes quirúrgicos.
Senzime은 ANESTHESIOLOGY® 2024에서 차세대 TetraGraph® 시스템을 공개하며, 수술 중 신경근 차단을 위한 고급 모니터링 기능을 갖추었습니다. 이 시스템은 TetraGraph® Adaptive Intelligence™를 포함하여 자동화된 워크플로와 실시간 데이터 모니터링을 제공합니다. 주요 개선 사항으로는 Level-of-Block Gauge™가 있는 혁신적인 사용자 인터페이스와 4배 높은 해상도의 6세대 EMG 알고리즘이 있습니다. 회사는 미국으로의 배송이 2024년 4분기부터 시작될 것이라고 발표했으며, 시스템은 수술 환자의 잔여 신경근 차단으로 인한 합병증을 줄이도록 설계되었습니다.
Senzime a dévoilé son système de nouvelle génération TetraGraph® lors de l'ANESTHESIOLOGY® 2024, offrant des capacités de surveillance avancées pour le blocage neuromusculaire pendant la chirurgie. Le système comprend TetraGraph® Adaptive Intelligence™, qui propose des flux de travail automatisés et une surveillance des données en temps réel. Les améliorations clés incluent une interface utilisateur révolutionnaire avec le Level-of-Block Gauge™ et un algorithme EMG de sixième génération avec une résolution 4 fois supérieure. La société a annoncé que les expéditions vers les États-Unis débuteront au quatrième trimestre 2024, le système étant conçu pour réduire les complications dues au blocage neuromusculaire résiduel chez les patients chirurgicaux.
Senzime hat auf der ANESTHESIOLOGY® 2024 sein nächstes TetraGraph® System vorgestellt, das über fortschrittliche Überwachungsfunktionen für neuromuskuläre Blockaden während der Operation verfügt. Das System umfasst TetraGraph® Adaptive Intelligence™, das automatisierte Arbeitsabläufe und eine Echtzeitdatenüberwachung bietet. Zu den wichtigsten Verbesserungen gehören eine revolutionäre Benutzeroberfläche mit Level-of-Block Gauge™ und ein EMG-Algorithmus der 6. Generation mit 4-mal höherer Auflösung. Das Unternehmen kündigte an, dass die Lieferungen in die USA im 4. Quartal 2024 beginnen werden, wobei das System darauf ausgelegt ist, Komplikationen durch residuale neuromuskuläre Blockaden bei chirurgischen Patienten zu reduzieren.
- Launch of next-generation TetraGraph® with enhanced monitoring capabilities
- Improved technology with 4x higher resolution EMG algorithm
- U.S. market expansion with shipments starting Q4 2024
- Sustainable design with upgradable software ensuring long-term value
- None.
Insights
The next-generation TetraGraph launch represents a significant advancement in neuromuscular monitoring technology. The system's enhanced features, including 4x higher resolution EMG algorithm and automated workflows, address critical market needs in perioperative monitoring. The timing of U.S. shipments in Q4 2024 positions Senzime to capitalize on the growing demand for precise monitoring solutions to prevent residual neuromuscular block complications.
The device's sustainable design with upgradable software creates a recurring revenue opportunity through potential software updates and ensures long-term market relevance. While the immediate revenue impact may be gradual, the improved technology and user interface could accelerate market adoption, particularly given the increasing focus on patient safety standards and updated clinical guidelines.
This product launch strengthens Senzime's competitive position in the perioperative monitoring market. The collaboration with anesthesiologists in development suggests strong product-market fit and potential for rapid clinical adoption. The automated workflows and precision-based monitoring align with healthcare's increasing focus on efficiency and reduced complications.
Given Senzime's market cap of
- TetraGraph® Adaptive Intelligence™: A smart suite of algorithms enabling precision-based monitoring with automated workflows throughout the perioperative journey, ensuring accurate and real-time neuromuscular assessments.
- Revolutionary User Interface: The TetraGraph® Level-of-Block Gauge™ simplifies the complexity of quantitative train-of-four (TOF) monitoring, making it easier to align with updated clinical guidelines.
- Advancing Beyond the Twitch: Built on decades of research, the system's 6th generation EMG algorithm boasts 4x higher resolution, offering unprecedented accuracy, real-time trends, and seamless interoperability.
UPPSALA,
Experience the full interactive Multichannel News Release here: https://www.multivu.com/senzime/9286551-en-senzime-unveils-next-generation-tetragraph-quantitative-train-of-four-monitor
The next-generation TetraGraph was designed in response to the growing need for more precise, reliable, and automated perioperative monitoring, aimed at reducing complications from residual neuromuscular block (rNMB), which continues to affect a significant percentage of surgical patients. Equipped with TetraGraph® Adaptive Intelligence™, the system delivers real-time data, helping clinicians enhance patient safety by making better-informed decisions throughout the perioperative journey.
"We are proud to have launched the next-generation TetraGraph system at ANESTHESIOLOGY® 2024 and excited to begin
The new TetraGraph also features a sustainable design with upgradable software, providing long-term reliability and future-proofing for evolving healthcare needs.
Senzime is excited to announce that
For more information, visit Senzime.com/NextGen.
Contact
Philip Siberg, CEO
+46 (0) 70 790 6734
philip.siberg@senzime.com
About Senzime
Senzime, headquartered in Uppsala,
Listed on the Nasdaq Stockholm Main Market (SEZI) and cross-traded on the OTCQX (SNZZF), Senzime is a beacon of progress, merging clinical excellence with shareholder value. Explore how Senzime is pioneering perioperative progress at senzime.com and follow the company on LinkedIn.
View original content:https://www.prnewswire.com/news-releases/senzime-successfully-unveils-next-generation-tetragraph-quantitative-train-of-four-monitor-at-anesthesiology-2024-us-shipments-begin-q4-2024-302287581.html
SOURCE Senzime
FAQ
When will Senzime (SNZZF) begin U.S. shipments of the new TetraGraph system?
What are the key features of Senzime's new TetraGraph system?
Where did Senzime (SNZZF) unveil its next-generation TetraGraph system?
